Tech Company Financing Transactions
Marginum Funding Round
Lynx Financial joined a $2.9 million Series A capital raise for Marginum. The round was announced on 8/25/2025.
Transaction Overview
Company Name
Announced On
8/25/2025
Transaction Type
Venture Equity
Amount
$2,900,000
Round
Series A
Investors
Proceeds Purpose
With this new capital, Marginum plans to pursue FDA clearance for its HIVEN aspirate tissue monitoring device.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Undisclosed
Kuopio, Undisclosed
Finland
Kuopio, Undisclosed
Finland
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
We enable safe and efficient monitoring of tissues during cancer surgery without compromising workflows. Marginum is developing ground-breaking tissue recognition technology, especially for oncological surgery. Our technology assists in safe and efficient identification of cancerous tissue with minimal damage to healthy tissues.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Samu Lehtonen
Browse more venture capital transactions:
Prev: 8/25/2025: Kiwi venture capital transaction
Next: 8/25/2025: Holo venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC investment data records reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs